Efficacy of triple therapy with thymalfasin, peginterferon α-2a, and ribavirin for the treatment of hispanic chronic HCV nonresponders Journal title: Annals of Hepatology Authors: Jorge Poo, Francisco Sánchez Ávila, David Kershenobich, Xochitl García Samper, Rocio Torres-Ibarra,... Subject(s):